Nonalcoholic fatty liver disease: from steatosis to cirrhosis (Q36382279)

13 August 2017

1 reference

title

Nonalcoholic fatty liver disease: from steatosis to cirrhosis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

13 August 2017

0 references

0 references

1 reference

1 reference

1

Geoffrey C Farrell

1 reference

13 August 2017

Claire Z Larter

2

1 reference

PubMed ID

16447287

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

13 August 2017

1 reference

13 August 2017

43

1 reference

13 August 2017

S99-S112

1 reference

13 August 2017

2 Suppl 1

1 reference

Fatty liver hepatitis and cirrhosis in obese patients

13 August 2017

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

1 reference

7 January 2021

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

7 January 2021

Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease

1 reference

7 January 2021

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

7 January 2021

Alcohol consumption and the risk of alcohol related cirrhosis in women.

1 reference

7 January 2021

Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related

1 reference

7 January 2021

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

1 reference

7 January 2021

Dietary composition and nonalcoholic fatty liver disease

1 reference

7 January 2021

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

7 January 2021

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

1 reference

7 January 2021

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

1 reference

7 January 2021

Selection and outcome of living donors for adult to adult right lobe transplantation

1 reference

7 January 2021

The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation

1 reference

7 January 2021

Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program

1 reference

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

7 January 2021

Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?

1 reference

7 January 2021

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

7 January 2021

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

1 reference

7 January 2021

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

1 reference

7 January 2021

Steatohepatitis in children

1 reference

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

7 January 2021

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

7 January 2021

Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases

1 reference

7 January 2021

Body fat topography as an independent predictor of fatty liver

1 reference

7 January 2021

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

1 reference

7 January 2021

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Fibrosis in patients with chronic hepatitis C: detection and significance

1 reference

7 January 2021

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

1 reference

7 January 2021

Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study

1 reference

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

7 January 2021

Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds

1 reference

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

7 January 2021

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

7 January 2021

Subacute liver failure in obese women

1 reference

7 January 2021

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

7 January 2021

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

7 January 2021

Diabetes duration and cause-specific mortality in the Verona Diabetes Study

1 reference

7 January 2021

Fasting in obesity: another cause of liver injury with alcoholic hyaline?

1 reference

7 January 2021

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

7 January 2021

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

7 January 2021

Steatosis: co-factor in other liver diseases.

1 reference

7 January 2021

Obesity and hepatocellular carcinoma

1 reference

7 January 2021

Recent concepts in non-alcoholic fatty liver disease

1 reference

7 January 2021

Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

1 reference

7 January 2021

Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.

1 reference

7 January 2021

Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation

1 reference

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

7 January 2021

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

7 January 2021

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease

1 reference

7 January 2021

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

7 January 2021

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

7 January 2021

Cytokines and the pathogenesis of non-alcoholic steatohepatitis

1 reference

7 January 2021

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

1 reference

7 January 2021

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

1 reference

7 January 2021

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

7 January 2021

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease

1 reference

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound

1 reference

7 January 2021

The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients

1 reference

7 January 2021

Focal manifestations of diffuse liver disease at MR imaging

1 reference

7 January 2021

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

7 January 2021

Controversies in liver biopsy: who, where, when, how, why?

1 reference

7 January 2021

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

7 January 2021

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

7 January 2021

Mitochondrial dysfunction and type 2 diabetes

1 reference

7 January 2021

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

7 January 2021

Fat in all the wrong places

1 reference

7 January 2021

Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats

1 reference

7 January 2021

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

1 reference

7 January 2021

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

7 January 2021

Mitochondrial abnormalities in non-alcoholic steatohepatitis

1 reference

7 January 2021

Signalling links in the liver: knitting SOCS with fat and inflammation.

1 reference

7 January 2021

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

1 reference

7 January 2021

Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

1 reference

7 January 2021

Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.

1 reference

7 January 2021

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

7 January 2021

Apolipoprotein synthesis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

1 reference

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

7 January 2021

Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

1 reference

7 January 2021

A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats

1 reference

7 January 2021

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Steatohepatitis: a tale of two "hits"?

1 reference

7 January 2021

Steatohepatitis induced by intragastric overfeeding in mice

1 reference

7 January 2021

TNF-alpha is not the cause of fatty liver disease in obese diabetic mice

1 reference

7 January 2021

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

1 reference

7 January 2021

Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

1 reference

7 January 2021

Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

7 January 2021

Effect of weight reduction on hepatic abnormalities in overweight patients.

1 reference

7 January 2021

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

7 January 2021

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

7 January 2021

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

1 reference

7 January 2021

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

7 January 2021

Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis

1 reference

7 January 2021

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

7 January 2021

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

7 January 2021

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

7 January 2021

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

7 January 2021

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

7 January 2021

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

7 January 2021

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20973

1 reference

13 August 2017

1 reference

PubMed ID

16447287